Edition:
United Kingdom

Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

56.84USD
23 Feb 2018
Change (% chg)

$-3.04 (-5.08%)
Prev Close
$59.88
Open
$59.97
Day's High
$60.05
Day's Low
$56.51
Volume
456,307
Avg. Vol
420,139
52-wk High
$99.45
52-wk Low
$45.42

Select another date:

Wed, Feb 21 2018

BRIEF-Clovis Oncology Receives Positive Trend Vote In European Regulatory Review Ovarian Cancer Treatment

* CLOVIS ONCOLOGY RECEIVES POSITIVE TREND VOTE FROM CHMP IN EUROPEAN REGULATORY REVIEW FOR RUCAPARIB OVARIAN CANCER TREATMENT INDICATION

BRIEF-Rucaparib MAA Referred By CHMP To Scientific Advisory Group On Oncology For Review

* RUCAPARIB MAA FOR THE OVARIAN CANCER TREATMENT INDICATION REFERRED BY CHMP TO SCIENTIFIC ADVISORY GROUP ON ONCOLOGY FOR REVIEW EXPECTED IN FEBRUARY 2018

BRIEF-Clovis Announces Priority Review Designation For Rucaparib Supplemental NDA

* CLOVIS ANNOUNCES PRIORITY REVIEW DESIGNATION FOR RUCAPARIB SUPPLEMENTAL NEW DRUG APPLICATION

BRIEF-Clovis Oncology reports Q3 adjusted shr loss of $1.24

* CLOVIS ONCOLOGY ANNOUNCES THIRD QUARTER 2017 OPERATING RESULTS

BRIEF-Clovis Oncology submits supplemental New Drug Application for rucaparib

* Clovis Oncology submits supplemental New Drug Application for rucaparib as maintenance treatment for patients with platinum-sensitive recurrent ovarian cancer

BRIEF-Clovis Oncology's Rucaparib Ariel3 study data published in The Lancet

* Clovis Oncology's Rucaparib Ariel3 study data published in The Lancet

Select another date: